Flat Medical Co., Ltd., Receives 510(k) clearance from the FDA for its EpiFaith® Syringe

LG Thin-Clients Feature Built-in RFID Capabilities Optimized for Use in Healthcare Facilities

Supporting its mission to help healthcare providers streamline operations and deliver exceptional patient care, LG Business Solutions USA introduced a new LG thin client...

Experien Group Acquired by Veranex

Veranex combines product development, regulatory, and market access expertise — globally and across complex and emerging markets.

Flat Medical Co., Ltd., the medtech company specializing in clinical safety solutions, announced it received 510(k) clearance from the U.S. Food and Drug Administration for its EpiFaith® syringe to deliver safe epidural locating solution.

“Post-dural puncture headache is a complication which unfortunately occurs in 1-2% of epidural procedures, when the needle is inadvertently advanced through the dura.” said Dr. Edward T. Riley, MD, Professor of Department of Anesthesiology, Perioperative and Pain Medicine at Stanford University Hospital. “EpiFaith is a novel device which has the potential to reduce this debilitating complication by providing a clear and objective indication for when the epidural space is encountered. EpiFaith may help both novice and expert proceduralists and reduce the suffering of thousands of patients.”

Based on the LOR technique, the EpiFaith® syringe is a physician-centered safeguard for epidural analgesia, indicated for painless labor, surgical anesthesia and chronic pain management. Compared with traditional practice that relies on the manual sense, EpiFaith® provides intuitive signal that tells anesthesiologists the arrival of epidural space, thus prevent the accidental puncture to dura, avoiding the risk of serious headache, paralysis, prolonged admission time, and related healthcare costs.

Previous to the FDA clearance, EpiFaith® has been CE certified since last October. By receiving FDA clearance this time, the Company says the official global launch of the EpiFaith® syringe will be in May, 2019. “It’s an exciting news that we have taken a step to the safer and intuitive puncture scenario. Now we have the opportunity to deliver safe epidural locating to millions of patients in the U.S.” said Dr. Joseph Luo, Chairman and CEO of Flat Medical. “EpiFaith for epidural is the start of our clinical safeguard pipeline, we will continuously ease the clinical risks through innovation on risky procedures.” Flat Medical just had an extremely successful exhibition at SOAP annual meeting, and will attend the OAA annual meeting and Euroanaesthesia 2019 in Newcastle and Vienna.



Graham Belgrave Named to the 2021 PharmaVOICE 100 List of Distinguished Leaders

At Advanced Clinical, and from previous organizations, Belgrave serves as a mentor to several colleagues, where he challenges them to think outside of the box and take risks.

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.